GLYCOMIMETICS INC
Total Trades
24
Buys
17
Sells
7
Largest Trade
$1M+
Insiders
10
Institutional Funds
4
Inst. Value
$15K–$50K
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Rock Edwin | Chief Medical Offi… | BUY | $50K–$100K | 305K | $0.26 | Jun 24, 2024 |
| Hahn Brian M. | SVP Finance, CFO | BUY | $1K–$15K | 18K | $0.25 | Jun 20, 2024 |
| Rock Edwin | Chief Medical Offi… | BUY | $50K–$100K | 65K | $1.38 | Sep 25, 2023 |
| Hahn Brian M. | SVP Finance, CFO | SELL | $1K–$15K | 4K | $1.95 | May 18, 2023 |
| JUNIUS DANIEL M | Director | BUY | $15K–$50K | 30K | $1.56 | May 11, 2023 |
| Johnson Bruce S | SVP & Chief Commer… | BUY | $15K–$50K | 14K | $1.57 | May 9, 2023 |
| Invus Public Equities, L.P. | 10% Owner | BUY | $100K–$500K | 100K | $1.70 | Feb 28, 2023 |
| Invus Public Equities, L.P. | 10% Owner | BUY | $500K+ | 400K | $1.78 | Feb 23, 2023 |
| Invus Public Equities, L.P. | 10% Owner | BUY | $1M+ | 1.5M | $2.00 | Feb 17, 2023 |
| Invus Public Equities, L.P. | 10% Owner | BUY | $15K–$50K | 11K | $3.24 | Feb 13, 2023 |
| SANDELL SCOTT D | 10% Owner | SELL | $1M+ | 3.7M | $3.14 | Jan 27, 2023 |
| SANDELL SCOTT D | 10% Owner | SELL | $100K–$500K | 71K | $2.76 | Jan 6, 2023 |
| SANDELL SCOTT D | 10% Owner | SELL | $1M+ | 398K | $2.98 | Jan 4, 2023 |
| Rock Edwin | Chief Medical Offi… | BUY | $100K–$500K | 110K | $2.25 | Dec 27, 2022 |
| JUNIUS DANIEL M | Director | BUY | $15K–$50K | 20K | $1.87 | Nov 18, 2022 |
| Rock Edwin | Chief Medical Offi… | BUY | $100K–$500K | 200K | $1.54 | Nov 16, 2022 |
| PEARSON TIMOTHY R | Director | BUY | $15K–$50K | 19K | $1.29 | Nov 14, 2022 |
| Semerjian Harout | CEO | BUY | $15K–$50K | 25K | $1.29 | Nov 14, 2022 |
| Hahn Brian M. | SVP Finance, CFO | BUY | $15K–$50K | 20K | $1.06 | Nov 14, 2022 |
| Magnani John L. | SVP of Research, CSO | BUY | $50K–$100K | 45K | $1.17 | Nov 14, 2022 |
| Girard Armand | SVP | BUY | $1K–$15K | 7K | $1.05 | Nov 14, 2022 |
| Magnani John L. | SVP of Research, CSO | SELL | $1K–$15K | 3K | $1.09 | Mar 10, 2022 |
| Girard Armand | SVP | SELL | $1K–$15K | 2K | $1.09 | Mar 10, 2022 |
| Hahn Brian M. | SVP Finance, CFO | SELL | $1K–$15K | 3K | $1.09 | Mar 10, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 4 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Intellectus Partners, LLC | 46K | $1K–$15K | SH |
| FIRETHORN WEALTH PARTNERS, LLC | 12K | $1K–$15K | SH |
| BlackRock, Inc. | 9K | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 7K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SC 13G · Nov 27, 2024
7.8%
5.0M shares
SC 13G/A · Nov 12, 2024
3.0%
196.5M shares
SC 13G · Nov 6, 2024
9.9%
6.4M shares
Adage Capital Management, L.P.
SC 13D · Nov 4, 2024
7.9%
5.1M shares
SC 13G/A · Nov 4, 2024
0.1%
50K shares
SC 13G/A · Aug 15, 2024
8.2%
5.3M shares
SC 13G · Aug 14, 2024
5.3%
3.4M shares
SC 13G/A · Jul 29, 2024
13.3%
8.6M shares
New Enterprise Associates 10, Limited Partnership
SC 13D/A · Mar 1, 2024
6.2%
4.0M shares
New Enterprise Associates 10, Limited Partnership
SC 13D/A · Feb 12, 2024
7.3%
4.7M shares
SC 13G/A · Feb 9, 2024
13.3%
858.9M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Jan 29, 2024
7.7%
5.0M shares
SC 13G · Feb 13, 2023
12.5%
6.6M shares
New Enterprise Associates 10, Limited Partnership
SC 13D/A · Feb 10, 2023
9.5%
5.0M shares